Track topics on Twitter Track topics that are important to you
Scientists at Stockholm University say their discovery of new Botulinum neurotoxin type X (BoNT/X) could lead to a new class of therapeutics related to intracellular membrane trafficking and secretion. Currently, Botulinum toxins are used to treat over 80 medical conditions, including muscle spasms, overactive bladder, chronic migraine, cervical dystonia, sweating and cerebral palsy. The researchers published their study ("Identification and characterization of a novel botulinum neurotoxin") in Nature Communications. “BoNT/X is a novel BoNT with a unique substrate profile,” write the investigators.” Its discovery…provides a novel tool for studying intracellular membrane trafficking and presents a new potential therapeutic toxin for modulating secretions in cells.” "The discovery of BoNT/X facilitates the development of diagnostics and countermeasures which is important if someone would be exposed to a toxic amount of the substance,", says Pal Stenmark, Ph.D., associate professor, department of biochemistry and biophysics, adding that the research team ...
Original Article: Novel Botulinum Neurotoxin May Treat Range of Medical DisordersNEXT ARTICLE
Arthritis Fibromyalgia Gout Lupus Rheumatic Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Diction...
Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...